These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32243494)

  • 41. The P2Y
    Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI
    Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-223-3p inhibits vascular calcification and the osteogenic switch of vascular smooth muscle cells.
    Han Y; Zhang J; Huang S; Cheng N; Zhang C; Li Y; Wang X; Liu J; You B; Du J
    J Biol Chem; 2021; 296():100483. PubMed ID: 33647318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification.
    Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen-Related Receptor γ Plays a Key Role in Vascular Calcification Through the Upregulation of BMP2 Expression.
    Kim JH; Choi YK; Do JY; Choi YK; Ha CM; Lee SJ; Jeon JH; Lee WK; Choi HS; Park KG; Lee IK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2384-90. PubMed ID: 26404484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification.
    Jia G; Stormont RM; Gangahar DM; Agrawal DK
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H523-32. PubMed ID: 22796540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein kinase A (PKA) inhibition reduces human aortic smooth muscle cell calcification stimulated by inflammatory response and inorganic phosphate.
    Toita R; Otani K; Kawano T; Fujita S; Murata M; Kang JH
    Life Sci; 2018 Sep; 209():466-471. PubMed ID: 30144450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs.
    Zhao XK; Zhu MM; Wang SN; Zhang TT; Wei XN; Wang CY; Zheng J; Zhu WY; Jiang MX; Xu SW; Yang XX; Duan YJ; Zhang BC; Han JH; Miao QR; Hu H; Chen YL
    Acta Pharmacol Sin; 2023 Aug; 44(8):1625-1636. PubMed ID: 36997664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
    Yao L; Sun YT; Sun W; Xu TH; Ren C; Fan X; Sun L; Liu LL; Feng JM; Ma JF; Wang LN
    Am J Nephrol; 2015; 41(1):28-36. PubMed ID: 25634106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.
    Xiao Q; Tang Y; Xia J; Luo H; Yu M; Chen S; Wang W; Pu L; Wang L; Li G; Li Y
    Ren Fail; 2022 Dec; 44(1):752-766. PubMed ID: 35509185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.
    Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM
    Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling.
    Willems BA; Furmanik M; Caron MMJ; Chatrou MLL; Kusters DHM; Welting TJM; Stock M; Rafael MS; Viegas CSB; Simes DC; Vermeer C; Reutelingsperger CPM; Schurgers LJ
    Sci Rep; 2018 Mar; 8(1):4961. PubMed ID: 29563538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling.
    Xiao Q; Tang Y; Luo H; Chen S; Chen R; Yan Z; Pu L; Wang L; Li G; Li Y
    Ren Fail; 2022 Dec; 44(1):1426-1442. PubMed ID: 36017689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt/β-catenin signaling pathway.
    Guo L; Wang Y; Li S; Zhou L; Li D
    Cell Signal; 2022 Dec; 100():110477. PubMed ID: 36162588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.
    Cai T; Sun D; Duan Y; Wen P; Dai C; Yang J; He W
    Exp Cell Res; 2016 Jul; 345(2):206-17. PubMed ID: 27321958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.
    Li KL; Chen J; Li ZH; Zhao L; He YN
    Cardiovasc J Afr; 2012 Jul; 23(6):e1-9. PubMed ID: 22143460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AT2 receptor stimulation inhibits phosphate-induced vascular calcification.
    Kukida M; Mogi M; Kan-No H; Tsukuda K; Bai HY; Shan BS; Yamauchi T; Higaki A; Min LJ; Iwanami J; Okura T; Higaki J; Horiuchi M
    Kidney Int; 2019 Jan; 95(1):138-148. PubMed ID: 30442332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
    Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
    Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting vascular smooth muscle cell dysfunction with xanthine derivative KMUP-3 inhibits abdominal aortic aneurysm in mice.
    Lai CH; Chang CW; Lee FT; Kuo CH; Hsu JH; Liu CP; Wu HL; Yeh JL
    Atherosclerosis; 2020 Mar; 297():16-24. PubMed ID: 32059119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hdac9 inhibits medial artery calcification through down-regulation of Osterix.
    He P; Yu H; Jiang L; Chen Z; Wang S; Macrae VE; Fu X; Zhu D
    Vascul Pharmacol; 2020 Sep; 132():106775. PubMed ID: 32702412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
    Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M
    J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.